查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595322

藥品可追溯性市場：按類型、最終用戶分類 - 2025-2030 年全球預測

Pharmaceutical Traceability Market by Type (Barcode, GPS, RFID), End User (Hospitals, Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥品追溯市場規模為150.1億美元，預計2024年將達到184.8億美元，複合年成長率為23.54%，2030年將達659.9億美元。

藥品可追溯性是指追蹤藥品的製造、分銷和配發的能力。其範圍包括旨在打擊假藥並確保患者安全和監管合規性的序列化、追蹤和檢驗系統。嚴格的全球監管要求推動了對藥品可追溯性的需求，例如美國《藥品供應鏈安全法案》(DSCSA) 和歐盟《假藥品指令》(FMD)，這些法規要求藥品從生產到銷售的整個過程都具有完整的可追溯性。應用程式涵蓋整個供應鏈，從製造商到批發商、藥房和醫療保健提供者，提高了透明度和安全性。最終用途主要包括藥品製造商、醫療保健分銷商、藥房和專注於醫療保健提供和安全的政府機構。影響該市場的關鍵成長要素包括假藥的增加、需要透明監控的複雜供應鏈業務以及區塊鏈和物聯網技術的進步以改善追蹤和資料完整性。整合高階分析和人工智慧以獲得預測性見解、改善即時決策和物流最佳化存在機會。然而，高實施成本、資料隱私問題以及不願採用新系統等挑戰可能會阻礙成長。此外，全球監管格局的分散需要一致的合規策略。創新在於制定通用的追溯標準、增強跨境互通性以及利用區塊鏈技術實現不可變記錄。進一步探索安全且具成本效益的追溯解決方案以滿足地區不同的監管需求也可能刺激成長。市場的動態本質表明技術解決方案不斷發展，重點關注永續性和成本效率，這使得它們對尋求在嚴格法律規範內創新的公司具有廣泛的吸引力。

主要市場統計
基準年[2023] 150.1億美元
預測年份 [2024] 184.8億美元
預測年份 [2030] 659.9億美元
複合年成長率（%） 23.54%

市場動態：揭示快速發展的藥品追溯市場的關鍵市場洞察

供需的動態交互作用正在改變藥品追溯市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 假藥增加
    • 政府對藥品的嚴格監管
    • 藥品貿易大幅成長
  • 市場限制因素
    • 解決方案成本高
  • 市場機會
    • 藥品追溯智慧解決方案簡介
    • 增加策略聯盟和投資
  • 市場挑戰
    • 缺乏有關藥品序列化的通用標準

波特五力：駕馭藥品追溯市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解藥品追溯市場的外部影響

外部宏觀環境因素在塑造藥品追溯市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解藥品追溯市場的競爭狀況

對藥品可追溯性市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣藥品可追溯市場供應商績效評估

FPNV 定位矩陣是評估藥品追溯市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析並繪製推薦藥品追溯市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，藥品追溯市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 假藥增加
      • 政府對藥品的嚴格監管
      • 藥品貿易大幅成長
    • 抑制因素
      • 解決方案高成本
    • 機會
      • 藥品追溯智慧解決方案簡介
      • 增加策略聯盟和投資
    • 任務
      • 藥品序號沒有通用標準。
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥品追溯市場：依類型

  • 條碼
  • GPS
  • RFID

第7章 藥品追溯市場：依最終使用者分類

  • 醫院
  • 藥局

第8章美洲藥品追溯市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太藥品追溯市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲藥品追溯市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Alien Technology LLC
  • AlpVision SA
  • Authentix Inc.
  • Avery Dennison Corporation
  • Bar Code India Ltd.
  • Cognex Corporation
  • Datalogic SpA
  • Dover Corporation
  • Impinj Inc.
  • Mettler Toledo International Inc.
  • Movilitas Consulting AG
  • Optel Group
  • rfxcel Corp.
  • SATO Holdings Corp.
  • TraceLink Inc.
  • Zebra Technologies Corp.
Product Code: MRR-957C47F90943

The Pharmaceutical Traceability Market was valued at USD 15.01 billion in 2023, expected to reach USD 18.48 billion in 2024, and is projected to grow at a CAGR of 23.54%, to USD 65.99 billion by 2030.

Pharmaceutical traceability refers to the ability to track the production, distribution, and dispensing of pharmaceutical products. Its scope encompasses serialization, tracking, and verification systems designed to combat counterfeit drugs, ensuring patient safety and regulatory compliance. The necessity for pharmaceutical traceability is driven by stringent global regulatory mandates, such as the U.S. Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (FMD), which require full traceability of pharmaceuticals from manufacturing to the point of sale. Applications span across the entire supply chain, from manufacturers to wholesalers, pharmacies, and healthcare providers, enhancing transparency and safety. The end-use scope primarily includes drug manufacturers, healthcare distributors, pharmacies, and governmental agencies focused on healthcare delivery and safety. Key growth factors influencing this market include increasing incidents of counterfeit drugs, complex supply chain operations necessitating transparent oversight, and technological advancements in blockchain and IoT for improved tracking and data integrity. Opportunities exist in the integration of advanced analytics and AI for predictive insights, improving real-time decision-making and optimizing logistics. However, challenges such as high implementation costs, data privacy concerns, and the resistance to adopting new systems may hinder growth. Moreover, the fragmentation of the global regulatory landscape necessitates consistent compliance strategies. Innovation lies in the development of universal traceability standards, enhancing interoperability across borders, and leveraging blockchain technology for immutable records. Additional research into secure yet cost-effective traceability solutions, adapted to varying regional regulatory demands, will also stimulate growth. The market's dynamic nature suggests a constant evolution of technological solutions, with a keen focus on sustainability and cost efficiency, appealing widely to firms seeking to innovate within stringent regulatory frameworks.

KEY MARKET STATISTICS
Base Year [2023] USD 15.01 billion
Estimated Year [2024] USD 18.48 billion
Forecast Year [2030] USD 65.99 billion
CAGR (%) 23.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Traceability Market

The Pharmaceutical Traceability Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing presence of counterfeit drugs
    • Strict governmental regulations for pharmaceutical drugs
    • Significant growth in trades of pharmaceutical products
  • Market Restraints
    • High costs of solutions
  • Market Opportunities
    • Introduction of smart solutions for pharmaceutical traceability
    • Increasing strategic alliances and investments
  • Market Challenges
    • Unavailability of general standards for drug serialization

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Traceability Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Traceability Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Traceability Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Traceability Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Traceability Market

A detailed market share analysis in the Pharmaceutical Traceability Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Traceability Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Traceability Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Traceability Market

A strategic analysis of the Pharmaceutical Traceability Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Traceability Market, highlighting leading vendors and their innovative profiles. These include Alien Technology LLC, AlpVision SA, Authentix Inc., Avery Dennison Corporation, Bar Code India Ltd., Cognex Corporation, Datalogic S.p.A., Dover Corporation, Impinj Inc., Mettler Toledo International Inc., Movilitas Consulting AG, Optel Group, rfxcel Corp., SATO Holdings Corp., TraceLink Inc., and Zebra Technologies Corp..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Traceability Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Barcode, GPS, and RFID.
  • Based on End User, market is studied across Hospitals and Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing presence of counterfeit drugs
      • 5.1.1.2. Strict governmental regulations for pharmaceutical drugs
      • 5.1.1.3. Significant growth in trades of pharmaceutical products
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of smart solutions for pharmaceutical traceability
      • 5.1.3.2. Increasing strategic alliances and investments
    • 5.1.4. Challenges
      • 5.1.4.1. Unavailability of general standards for drug serialization
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Traceability Market, by Type

  • 6.1. Introduction
  • 6.2. Barcode
  • 6.3. GPS
  • 6.4. RFID

7. Pharmaceutical Traceability Market, by End User

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Pharmacies

8. Americas Pharmaceutical Traceability Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Traceability Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Traceability Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alien Technology LLC
  • 2. AlpVision SA
  • 3. Authentix Inc.
  • 4. Avery Dennison Corporation
  • 5. Bar Code India Ltd.
  • 6. Cognex Corporation
  • 7. Datalogic S.p.A.
  • 8. Dover Corporation
  • 9. Impinj Inc.
  • 10. Mettler Toledo International Inc.
  • 11. Movilitas Consulting AG
  • 12. Optel Group
  • 13. rfxcel Corp.
  • 14. SATO Holdings Corp.
  • 15. TraceLink Inc.
  • 16. Zebra Technologies Corp.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL TRACEABILITY MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL TRACEABILITY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL TRACEABILITY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL TRACEABILITY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL TRACEABILITY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL TRACEABILITY MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY BARCODE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY GPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY RFID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. PHARMACEUTICAL TRACEABILITY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. PHARMACEUTICAL TRACEABILITY MARKET, FPNV POSITIONING MATRIX, 2023